A recently published study by FMI expects the global Central Pain Syndrome Management Market to augment at a 5% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 100 Billion is expected for the market. As per the World Health Organization (WHO), the share of the world’s …
Category Archives: Healthcare Trends
COVID-19 Vaccine Packaging and Delivery Devices Market in China is projected to expand at a CAGR of around 7.9% from 2023 to 2033
The COVID-19 Vaccine Packaging and Delivery Devices Market study report, just released by Future Market Insights, estimates that global sales of the Covid-19 Vaccine Packaging and Delivery Devices will reach US$ 1.1 billion in 2022. With a CAGR of 7.1% between 2023 and 2033, the market is anticipated to reach a worth of US$ 2.2 …
Strong Growth Forecasted for Ocular Tuberculosis Therapeutics Market | Expected Valuation of US$ 753.2 Million by 2032
[Report of 333 Pages] The global ocular tuberculosis therapeutics market is expected to be worth $753.2 million by 2032, up from $405.0 million in 2022, and to grow at a 5.8% CAGR during the forecast period.Ocular Tuberculosis Therapeutics Market: OverviewThere are different mechanisms through which ocular tuberculosis may occur, involving the lid, conjunctiva, cornea, and sclera. In …
Rising Market Growth Anticipated in the Serum Separation Gels Market | Valued at US$ 12.39 Billion by 2032, as per FMI Study
[Report of 250 Pages] The serum separation gels market is expected to grow at a 5% CAGR during the forecast period, from US$ 7.61 billion in 2022 to US$ 12.39 billion by 2032. The Global Serum Separation Gels market study provides critical information related to the global, regional and top players including Serum Separation Gels market share analysis, winning …
Steady Growth Anticipated in the Bioprocess Integrity Testing Systems Market | CAGR of 5.7% to Reach a Value of US$ 136.6 Million by 2032
The global Bioprocess Integrity Testing Systems Market will be worth US$ 74.2 million in 2022, rising at a 5.7% CAGR to US$ 136.6 million between 2022 and 2032. Increased availability of fully automated integrity test solutions is related to growth. The biscuit mixes market grew at a CAGR of 5.0% between 2016 and 2021. Bioprocess integrity testing …
Remarkable Growth Expected in the Late Stage Chronic Kidney Disease Therapeutics Market | CAGR of 11.6% through 2032
[Report of 250 Pages] In 2019, the global demand for late-stage chronic kidney disease therapeutics was estimated to be around $4.7 billion. However, due to the rising prevalence of chronic kidney disease around the world, the global late stage kidney disease therapeutics market is expected to surpass US$ 11.1 billion in 2027 and grow at a robust …
Growing Demand for Automated Cannabis Testing | Projected CAGR of 11% to 13% from 2022 to 2032
[Report of 250 Pages] During the forecast period of 2022 to 2032, global automated cannabis testing demand is expected to grow at a rapid CAGR of 11% to 13%. The market is expanding due to the increasing use of automation in cannabis testing laboratories and the global demand for high-quality cannabis-based medical products.Cannabis is a psychoactive drug …
Anticipated Expansion of Airway Disease Treatment Market: CAGR of 5.2% from 2022 to 2032 | FMI Study
The global airway disease treatment market is projected to amass a revenue of around US$ 3,495.3 million by 2032, up from US$ 1,996.1 million in 2022 moving forward with a CAGR of 5.2% during the forecast period. LABA-ICS, LAMA-ICS, triple treatment, and other related drugs are among the pharmaceuticals used in combination therapy for COPD. Combination therapy is gaining popularity due …
Future Trends in Hadron Therapy Market: Expected Valuation of US$ 4,812 Million by 2032 | FMI Study
The global market for hadron therapy is expected to be worth $1,412.9 million in 2022 and $4,812 million by 2032. The market is expected to grow at a CAGR of 11.8% from 2022 to 2032, up from 17.1% from 2016 to 2021. The rising number of cancer cases worldwide is expected to drive the global hadron therapy …
Growth Prospects of Hepatitis C Virus (HCV) Testing Market | Estimated CAGR of 5.6% from 2022 to 2032 | FMI
[Report of 297 Pages] By the end of 2022, it is anticipated that the market for hepatitis C virus (HCV) testing will be worth US$733.6 Million. A CAGR of 5.6% has been predicted for the market during the forecast period of 2022 to 2032, with an anticipated closing value of US$ 1341.7 Million. The industry expanded at …